THC and Ketamine Effects in Humans: Relation to Neural Oscillations and Psychosis
An Electrophysiological Examination of CB1 and NMDA Receptors in Humans
Sponsor: Brain & Behavior Research Foundation
Listed as NCT04199468, this PHASE1 trial focuses on Cannabis and Ketamine and remains completed. Sponsored by Brain & Behavior Research Foundation, it has been updated 11 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Apr 2024 — Jul 2024 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
May 2023 — Apr 2024 [monthly]
Active Not Recruiting PHASE1
-
Sep 2022 — May 2023 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
▶ Show 6 earlier versions
-
Feb 2022 — Sep 2022 [monthly]
Recruiting PHASE1
-
Feb 2021 — Feb 2022 [monthly]
Recruiting PHASE1
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE1
-
Sep 2020 — Jan 2021 [monthly]
Recruiting PHASE1
-
Jul 2020 — Sep 2020 [monthly]
Recruiting PHASE1
-
Jan 2020 — Jul 2020 [monthly]
Recruiting PHASE1
First recorded
Sep 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Brain & Behavior Research Foundation
- Yale University
For direct contact, visit the study record on ClinicalTrials.gov .